load

Valenta Pharm Is Named Number One among Russian Pharmaceutical Manufacturers  In Terms of Prescriptions by Policlinic Doctors

Valenta Pharm Is Named Number One among Russian Pharmaceutical Manufacturers In Terms of Prescriptions by Policlinic Doctors

12.02.2019

Valenta Pharm is on the TOP25 pharmaceutical companies that demonstrate the highest dynamics of Compound Annual Growth Rate (CAGR) in doctors’ prescriptions1. The company also is a leader among Russian pharmaceutical companies in terms of prescriptions made by policlinic doctors2.

According to the findings of the survey, Valenta Pharm’s CAGR in doctors’ prescriptions was 9% during 2016 - 20181.

Dmitry Semenenko, Head of Field Force Department at Valenta Pharm: “The development and further launch of innovative products is our key priority. The leadership in share of doctors’ prescriptions demonstrates the high level of trust to us from healthcare professionals and patients. We produces our medicines on the state-of-art plant in accordance with all Russian and international quality standards ICH: GCP, GLP и GMP. And we are confident that our products meets the highest quality standards”.

  • 1According to PrIndexTM Study “The monitoring of medicines prescription” *, Valenta Pharm’s medicines were prescribed in large cities in 1.86% cases (autumn 2018), 1.67% cases (autumn 2017) and 1.42% in 2016 by policlinic doctors of 16 different specialties. Valenta Pharm’s Compound Annual Growth Rate (CAGR) in doctors’ prescriptions totaled in 9% during 2016-2018; it is a leader in terms of this indicator.
  • 2According to PrIndexTM Study “The monitoring of medicines prescription” *, Valenta Pharm’s medicines were prescribed in large cities in 1.86% cases (autumn 2018), 1.67% cases (autumn 2017) and 1.42% in 2016 by policlinic doctors of 16 different specialties. As of autumn 2018, Valenta Pharm is on the thirteen place among all pharmaceutical companies and on the first place among Russian pharmaceutical companies.
  • *according to the PrIndexTM Study “The monitoring of medicines prescription”, conducted by Ipsos Comcon LLC in autumn 2018 in the largest Russian cities (Moscow. St Petersburg, Ekaterinburg, Nizhniy Novgorod, Novosibirsk, Samara, Rostov-on-Don, Voronezh, Kazan, Ufa, Omsk, Perm, Chelyabinsk, Volgograd, Yaroslavl. The number of participant was 4,309 policlinic doctors of 16 different specialties (GPs, cardiologists, gastroenterologists, dermatologists, neurologists, pulmonologists, allergologists, endocrinologists, psychiatry, pediatricians, ORT specialists, ophthalmologists, rheumatologists, surgeons. In total, they were visited by 510,282 patients and made 1,109,511 prescriptions during 7 working days.